E For L Aim PCL (BKK:EFORL-R) Current Accrued Expense: ฿13 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BKK:EFORL-R E For L Aim PCL BKK:EFORL-R
40 GF Score
Price ฿0.12
GF Value ฿0.14
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is E For L Aim PCL Current Accrued Expense?

E For L Aim PCL BKK:EFORL-R 40 Current Accrued Expense is ฿13 Mil as of Jun. 2026. GuruFocus rates BKK:EFORL-R with a GF Score™ of 40/100 and a GF Value™ of ฿0.14 (Modestly Undervalued). The stock has 7 warning signs investors should review.

E For L Aim PCL's Current Accrued Expense for the quarter that ended in Jun. 2026 was ฿13 Mil.

E For L Aim PCL's quarterly Current Accrued Expense declined from Dec. 2025 (฿15 Mil) to Mar. 2026 (฿14 Mil) and declined from Mar. 2026 (฿14 Mil) to Jun. 2026 (฿13 Mil).

E For L Aim PCL's annual Current Accrued Expense increased from Dec. 2023 (฿15 Mil) to Dec. 2024 (฿17 Mil) but then declined from Dec. 2024 (฿17 Mil) to Dec. 2025 (฿15 Mil).

E For L Aim PCL Current Accrued Expense Historical Data

* Premium members only.

The historical data trend for E For L Aim PCL's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

E For L Aim PCL Current Accrued Expense Chart

E For L Aim PCL Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Current Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 19.12 19.03 15.16 17.45 14.76

E For L Aim PCL Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Current Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.23 13.65 14.76 13.79 13.25
BKK:EFORL-R
40GF Score
E For L Aim PCL BKK:EFORL-R
Current Accrued Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

E For L Aim PCL Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

What does a Current Accrued Expense of ฿13 Mil mean?
E For L Aim PCL (BKK:EFORL-R) has a Current Accrued Expense of ฿13 Mil as of Jun. 2026. Current Accrued Expense records the total amount of accrued expenses. View historical data on E For L Aim PCL and its competitors.
Is E For L Aim PCL's Current Accrued Expense too high?
E For L Aim PCL's current Current Accrued Expense is ฿13 Mil. Overall, E For L Aim PCL has a GF Score™ of 40/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does E For L Aim PCL's Current Accrued Expense compare to MCK and COR?
E For L Aim PCL's Current Accrued Expense of ฿13 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Accrued Expense for a Medical Distribution company?
A good Current Accrued Expense depends on the Medical Distribution industry context. However, Current Accrued Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Accrued Expense mean?
A high Current Accrued Expense can signal that a stock is expensive relative to its fundamentals. Current Accrued Expense records the total amount of accrued expenses. View historical data on E For L Aim PCL and its competitors. E For L Aim PCL's current Current Accrued Expense is ฿13 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is E For L Aim PCL stock overvalued right now?
Based on GuruFocus' analysis, E For L Aim PCL (BKK:EFORL-R) is currently considered Modestly Undervalued. The stock's GF Value™ is ฿0.14, compared to a current price of ฿0.12 — trading 14.3% below its estimated fair value. The current Current Accrued Expense is ฿13 Mil. E For L Aim PCL's overall GF Score™ is 40/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Accrued Expense calculated?
Current Accrued Expense is calculated from a company's financial statements. For E For L Aim PCL (BKK:EFORL-R), the current Current Accrued Expense is ฿13 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is E For L Aim PCL (BKK:EFORL-R) Overvalued in 2026?

Based on GuruFocus' analysis, E For L Aim PCL stock appears to be undervalued. The current stock price of ฿0.12 is trading 14.3% below its estimated GF Value™ of ฿0.14. GuruFocus considers E For L Aim PCL to be Modestly Undervalued.

Key valuation signals for BKK:EFORL-R:

  • Current Accrued Expense: ฿13 Mil
  • GF Value™: ฿0.14 vs. price of ฿0.12 (14.3% below fair value)
  • GF Score™: 40/100 with 7 warning signs

No single metric tells the full story. See the BKK:EFORL-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

E For L Aim PCL Business Description

Other Exchanges EFORL:Thailand
Address 432, Rajavithi road, Bangyeekhan Sub District, Bangplad District, Bangkok, THA, 10700
E For L Aim PCL is engaged in the distribution of medical devices and equipment. The company and subsidiary have distributor agreements for medical devices and equipment with foreign companies. Its products include Patient Monitor System, Central Monitors System, Defibrillator, Automated External Defibrillator (AED), Electrocardiographs, Electroencephalogram (EEG), PSG System (Sleep Labs), and Accessories and Consumables. The group is principally engaged in one operating segment which is the distribution of medical device and equipment and providing service of medical equipment. Their operations are carried out in Thailand.
40GF Score

Get the complete analysis for BKK:EFORL-R

Current Accrued Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿0.12
Price
฿0.14
GF Value